Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Solarea Bio has raised $9.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Solarea Bio's investors include S2G Investments, Viking Global Investors, Rising Tide, National Institute on Aging, Bold Capital Partners.
Solarea Bio is headquartered in Cambridge, United States.
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Solarea Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Solarea Bio — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/solarea-bio. Accessed July 19, 2026.
VCBacked. (2025). Solarea Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/solarea-bio
{{cite web |title=Solarea Bio — Funding & Investors |url=https://www.vcbacked.co/company/solarea-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated